Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer.

[1]  J. Goméz,et al.  Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study. , 1996, The American journal of surgical pathology.

[2]  A. Anand,et al.  Detection of residual prostate cancer after external radiotherapy , 1995, Cancer.

[3]  R. Babaian,et al.  Detection of residual prostate cancer after external radiotherapy. Role of prostate specific antigen and transrectal ultrasonography , 1995, Cancer.

[4]  F. Labrie,et al.  Down-staging of early stage prostate cancer before radical prostatectomy: The first randomized trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonist , 1994 .

[5]  G. Zagars.  Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy. , 1994, The Journal of urology.

[6]  A. Zietman,et al.  Localized carcinoma of the prostate (Stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy , 1993, Cancer.

[7]  B. Têtu,et al.  Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial. , 1993, Clinical and investigative medicine. Medecine clinique et experimentale.

[8]  P. Scardino,et al.  PSA after definitive radiotherapy for clinically localized prostate cancer. , 1993, The Urologic clinics of North America.

[9]  G. Zagars.  Serum PSA as a tumor marker for patients undergoing definitive radiation therapy. , 1993, The Urologic clinics of North America.

[10]  S. Cha,et al.  Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. V. von Eschenbach,et al.  Prostate‐specific antigen. An important marker for prostate cancer treated by external beam radiation therapy , 1993, Cancer.

[12]  I. Kaplan,et al.  Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup. , 1993, The Journal of urology.

[13]  J. Montie,et al.  Frequency of residual neoplasm in the prostate following three‐dimensional conformal radiotherapy , 1993, The Prostate.

[14]  D. Kuban,et al.  Prognostic significance of post-irradiation prostate biopsies. , 1993, Oncology.

[15]  E. Messing,et al.  Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  G. Hanks,et al.  Long term results of treatment of prostate cancer in the USA in 1973, 1978, and 1983 , 1992 .

[17]  R. Mohan,et al.  Acute morbidity and PSA response in patients with carcinoma of the prostate treated with three dimensional conformal radiation therapy , 1992 .

[18]  G. Zagars.  Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy. , 1992, International journal of radiation oncology, biology, physics.

[19]  I. Kaplan,et al.  The clinical significance of a positive post-irradiation prostatic biopsy without metastases. , 1992, International journal of radiation oncology, biology, physics.

[20]  L. Verhey,et al.  Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: correlation with original histological grade and current prostate specific antigen levels. , 1991, The Journal of urology.

[21]  C B Begg,et al.  The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. , 1991, International journal of radiation oncology, biology, physics.

[22]  R. Gittes.  Carcinoma of the prostate. , 1991, The New England journal of medicine.

[23]  P. Rubin,et al.  Outcome for lymph node dissection negative T-1b, T-2 (A-2,B) prostate cancer treated with external beam radiation therapy in RTOG 77-06. , 1991, International journal of radiation oncology, biology, physics.

[24]  Porter At,et al.  The role of cytoreduction prior to definitive radiotherapy in locally advanced prostate cancer--the Canadian perspective. , 1990 .

[25]  R. Cox,et al.  Status of radiation treatment of prostate cancer at Stanford University. , 1989, NCI monographs : a publication of the National Cancer Institute.

[26]  Hanks Ge.  External-beam radiation therapy for clinically localized prostate cancer: patterns of care studies in the United States. , 1988 .

[27]  W. Shipley,et al.  Radiation therapy for localized prostate carcinoma: experience at the Massachusetts General Hospital (1973-1981). , 1988, NCI monographs : a publication of the National Cancer Institute.

[28]  D. Kuban,et al.  Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma. , 1987, Urology.

[29]  A. V. von Eschenbach,et al.  Stage C adenocarcinoma of the prostate. An analysis of 551 patients treated with external beam radiation , 1987, Cancer.

[30]  E. Rosen,et al.  Radiotherapy for prostate carcinoma: the JCRT experience (1968-1978). II. Factors related to tumor control and complications. , 1985, International journal of radiation oncology, biology, physics.

[31]  G. Hanks.  ASTRO 1984 Presidential Address. Optimizing the radiation treatment and outcome of prostate cancer. , 1984, International journal of radiation oncology, biology, physics.

[32]  S. Leibel,et al.  Patterns of care outcome studies: results of the national practice in adenocarcinoma of the prostate. , 1984, International journal of radiation oncology, biology, physics.

[33]  F. Freiha,et al.  Carcinoma of the prostate: Results of post‐irradiation biopsy , 1984, The Prostate.

[34]  J. Cox,et al.  Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma, Stage III, predict long-term survival? , 1981, International journal of radiation oncology, biology, physics.

[35]  G. Leach,et al.  Radiotherapy for prostatic carcinoma: post-irradiation prostatic biopsy and recurrence patterns with long-term followup. , 1982, The Journal of urology.

[36]  J. Lattimer,et al.  Carcinoma of the prostate: Treatment with external radiotherapy , 1978, Cancer.